Treatment Registry
TR-0643 ActiveRecorded September 2, 2026

Compounded semaglutide

Sold by DadVantage · Injection, vial · every compounded semaglutide record

What you actually pay

Per month

$250

Medication · Semaglutide / B12 Injection, 4 weeks$200
Required membership$50

Added from the figures recorded below.

Price

TermPer monthCharged today
Semaglutide / B12 Injection, 4 weeks

Semaglutide / B12 Injection $200: 4 weeks

source

Per month$200Charged today$200
Semaglutide / B12 Injection, 12 weeks (save $100)

$500: 12 weeks (Save $100)

source

Per month$166.67Charged today$500
Semaglutide / B12 Injection, 20 weeks (save $150)

$650: 20 weeks (Save $150)

source

Per month$130Charged today$650
Visit DadVantage

We earn nothing from this link. DadVantage has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberLive visit
Cancellation“No insurance games. No hidden fees. Every cost is on this page. Cancel anytime: no penalties, no questions.”
MembershipRequired. $50 per month. “Weight Loss Optimization Follow-Ups $50/month subscription. Includes weekly self-injections/orals, monthly follow-ups, plan adjustments, diet/exercise coaching, and direct provider access. Medication costs separate.”

Not yet checked: pharmacy, states and consult fee.

Recorded from dadvantagemenshealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The itemized Semaglutide/B12 and Tirzepatide/Niacinamide medication prices are quoted in weeks on the page; term/perMonth above are converted assuming ~4.33 weeks/month, same convention used elsewhere in this project. A separate $17,995/year 'Weight Loss Executive Bundle (GLP-1)' also exists but doesn't specify semaglutide vs. tirzepatide, so it isn't broken into a price entry here.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0643
Readings
1

Related records

What else DadVantage sells

All DadVantage programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Cite this entry

Treatment Registry. (2026). DadVantage compounded semaglutide (TR-0643). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0643

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.